Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02185183

NCT02185183
Completed Phase 2

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease (a type of inflammatory bowel condition)

Who may not be able to join:

  • You are currently taking medications or have a condition that weakens or suppresses your immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 2
Sponsor
Hadassah Medical Organization
Registry
clinicaltrials_gov
Start date
1 January 2008
Est. completion
1 January 2010

Primary endpoints

Number of Participants With Improved in Disease Activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov